Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: MOLECULAR EXPRESS, INC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2021-08-01 to 2023-07-31
Current total value of award: $569807
Description: DEVELOPMENT OF A VESIVAS IMMUNOSIMILAR FORMULATION EDITED BY LNGUYEN_NIH ON 09/29/2021 15:54:41 EDITED BY LNGUYEN_NIH ON 09/29/2021 15:54:52